157 related articles for article (PubMed ID: 12885844)
1. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis.
Tanaka C; Uzawa K; Shibahara T; Yokoe H; Noma H; Tanzawa H
J Dent Res; 2003 Aug; 82(8):607-11. PubMed ID: 12885844
[TBL] [Abstract][Full Text] [Related]
2. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis.
Zhou S; Qu X; Yu Z; Zhong L; Ruan M; Ma C; Wang M; Zhang C; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Hsue SS; Lin LM
Arch Oral Biol; 2005 Jun; 50(6):593-8. PubMed ID: 15848153
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
7. Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis.
Pannone G; Bufo P; Serpico R; Rubini C; Zamparese R; Corsi F; Pedicillo MC; Pannone G; Staibano S; De Rosa G; Lo Muzio L
Histol Histopathol; 2007 Nov; 22(11):1241-9. PubMed ID: 17647197
[TBL] [Abstract][Full Text] [Related]
8. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers.
Jane C; Nerurkar AV; Shirsat NV; Deshpande RB; Amrapurkar AD; Karjodkar FR
J Oral Pathol Med; 2006 Nov; 35(10):595-601. PubMed ID: 17032391
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.
De Maria S; Pannone G; Bufo P; Santoro A; Serpico R; Metafora S; Rubini C; Pasquali D; Papagerakis SM; Staibano S; De Rosa G; Farina E; Emanuelli M; Santarelli A; Mariggiò MA; Lo Russo L; Lo Muzio L
J Cancer Res Clin Oncol; 2009 Jan; 135(1):107-16. PubMed ID: 18642030
[TBL] [Abstract][Full Text] [Related]
10. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.
Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Mariggiò A; Salvatore G; Chieffi P; Tramontano D; De Rosa G; Altieri DC
Exp Mol Pathol; 2001 Jun; 70(3):249-54. PubMed ID: 11418003
[TBL] [Abstract][Full Text] [Related]
11. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.
Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J
Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression in oral squamous cell carcinoma.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Rubini C; Mariggiò MA; Procaccini M; Ferrari F; De Rosa G; Altieri DC
Br J Cancer; 2003 Dec; 89(12):2244-8. PubMed ID: 14676801
[TBL] [Abstract][Full Text] [Related]
13. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
[TBL] [Abstract][Full Text] [Related]
14. Survivin, a potential early predictor of tumor progression in the oral mucosa.
Lo Muzio L; Pannone G; Leonardi R; Staibano S; Mignogna MD; De Rosa G; Kudo Y; Takata T; Altieri DC
J Dent Res; 2003 Nov; 82(11):923-8. PubMed ID: 14578507
[TBL] [Abstract][Full Text] [Related]
15. Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology.
Nakayama K; Kamihira S
Leuk Lymphoma; 2002 Dec; 43(12):2249-55. PubMed ID: 12613509
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
17. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis.
Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kato Y; Saito K; Nakashima D; Higo M; Kouzu Y; Ono K; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Br J Cancer; 2007 Sep; 97(6):792-801. PubMed ID: 17726464
[TBL] [Abstract][Full Text] [Related]
18. The phosphorylation of survivin Thr34 by p34cdc2 in carcinogenesis of oral submucous fibrosis.
Zhou S; Li L; Jian X; Ou X; Jiang H; Yao Z; Xu C; Peng J
Oncol Rep; 2008 Nov; 20(5):1085-91. PubMed ID: 18949405
[TBL] [Abstract][Full Text] [Related]
19. Expression of inhibitor of apoptosis family proteins in human oral squamous cell carcinogenesis.
Chen YK; Huse SS; Lin LM
Head Neck; 2011 Jul; 33(7):985-98. PubMed ID: 20967871
[TBL] [Abstract][Full Text] [Related]
20. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Scheper MA; Nikitakis NG; Sauk JJ
Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
